Kiernan Seth - Feb 28, 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
VP, Chief Commercial Officer
Signature
/s/ Kiernan Seth, Ph.D.
Stock symbol
LXRX
Transactions as of
Feb 28, 2023
Transactions value $
-$25,634
Form type
4
Date filed
3/1/2023, 03:55 PM
Previous filing
Feb 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +14.8K +67.83% 36.7K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +5.29K +14.4% 42K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +23K +54.69% 64.9K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Tax liability -$25.6K -11.8K -18.19% $2.17 53.1K Feb 28, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -14.8K -100% 0 Feb 28, 2023 Common Stock 14.8K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -5.29K -50% 5.29K Feb 28, 2023 Common Stock 5.29K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -23K -33.33% 45.9K Feb 28, 2023 Common Stock 23K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.